Clinical Trials
3 trialsNCT04217317 2025-05-02
CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma
Wake Forest University Health Sciences
Phase 2 Terminated
NCT02424045 2018-09-06
Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma
Samsung Medical Center
Phase 2 Completed
NCT00959686 2013-02-12
BENTLY
French Innovative Leukemia Organisation
Phase 2 Completed